1. Markus, Hugh S. 2023. HDAC9 Inhibition as a Novel Treatment for Stroke. In Stroke, 54, 3182-3189. doi:10.1161/STROKEAHA.123.044862. https://pubmed.ncbi.nlm.nih.gov/37942644/
2. Shroff, Natasha, Ander, Bradley P, Zhan, Xinhua, Sharp, Frank R, Jickling, Glen C. 2018. HDAC9 Polymorphism Alters Blood Gene Expression in Patients with Large Vessel Atherosclerotic Stroke. In Translational stroke research, 10, 19-25. doi:10.1007/s12975-018-0619-x. https://pubmed.ncbi.nlm.nih.gov/29651704/
3. Sanguigno, Luca, Guida, Natascia, Anzilotti, Serenella, Annunziato, Lucio, Formisano, Luigi. 2023. Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death. In International journal of biological sciences, 19, 2695-2710. doi:10.7150/ijbs.80735. https://pubmed.ncbi.nlm.nih.gov/37324938/
4. Han, Yan, Sun, Wenzhu, Wang, Li, Sun, Jielin, Xu, Jianfeng. 2013. HDAC9 gene is associated with stroke risk in a Chinese population. In Experimental biology and medicine (Maywood, N.J.), 238, 842-7. doi:10.1177/1535370213494650. https://pubmed.ncbi.nlm.nih.gov/23828597/
5. Grbić, Emin, Gorkič, Nataša, Pleskovič, Aleš, Petrovič, Daniel, Fras, Zlatko. 2020. Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort. In Lipids in health and disease, 19, 71. doi:10.1186/s12944-020-01255-1. https://pubmed.ncbi.nlm.nih.gov/32284067/
6. Linares, Aurélien, Assou, Said, Lapierre, Marion, Boulle, Nathalie, Cavaillès, Vincent. 2019. Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers. In Molecular oncology, 13, 1534-1547. doi:10.1002/1878-0261.12505. https://pubmed.ncbi.nlm.nih.gov/31099456/
智鼠故事 
